THE POWER OF THE LITTLE BLUE PILL: INNOVATIONS AND IMPLICATIONS OF LIFESTYLE DRUGS IN AN AGING POPULATION
The launch of Viagra in April 1998 led to a historically unprecedented high usage of erectile dysfunction (ED) drugs. We test whether Viagra's introduction significantly influenced outcomes for its target population such as sexually transmitted disease (STD) rates of older men, as well as its n...
Gespeichert in:
| Veröffentlicht in: | Economic inquiry 2015-01, Vol.53 (1), p.540-556 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 556 |
|---|---|
| container_issue | 1 |
| container_start_page | 540 |
| container_title | Economic inquiry |
| container_volume | 53 |
| creator | LaRiviere, Jacob Wolff, Hendrik |
| description | The launch of Viagra in April 1998 led to a historically unprecedented high usage of erectile dysfunction (ED) drugs. We test whether Viagra's introduction significantly influenced outcomes for its target population such as sexually transmitted disease (STD) rates of older men, as well as its nontarget populations, such as divorces, natality, the distribution of the age spread within couples, female STDs, and sexual assault rates. We find causal evidence that Viagra's introduction increased gonorrhea rates in older men by 15%–28%. We find no significant evidence of any effects on other variables. We take this as evidence that this lifestyle drug causes significant changes in choices only which affect short‐term outcomes, while long‐term planned decisions are unaffected. Overall, we find that the welfare impacts of Viagra with respect to our outcomes of interest are positive and large. (JEL I1, J1, O33) |
| doi_str_mv | 10.1111/ecin.12147 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1636460241</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A397134371</galeid><sourcerecordid>A397134371</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6487-f3e9bb69aba8967260e4c224c0c6f3c9bdee1f9a9bc1d7a3bafb53e2eb6f8d133</originalsourceid><addsrcrecordid>eNp90l1vmzAUBmA0bdKydjf7BUi72aaRYRts2F2aEmrJhawhq7Ybyzgmc0ugw6C1_35Ok31kigYSFvbzHh1Zx3FeAX8M7PNBSd2MAQQBeeKMQIBDj8A4fOqMfD8OPRhG6Lnzwpgb3_cRDsORo4uLxJ3n18mVm8_c7Q-jRcES94wt7QFl7KNLsyz_PCloni3cSXbu0ss5o9P9hk0xOksWxRcbOr9apgvrLXMnKc1SW3q-ZI_01HlWidqol_v1xFnOkmJ64bE8tdWYJ3EQEa9CKi5LHItSRDEmEPsqkBAG0pe4QjIuV0qBKhZxKcGKCFSKqgyRgqrEVbQCCJ04b3Z177r2-6BMzzfaSFXXolHtYDjACAfYhwGw9PU_9KYdusZ2xwGBBEdRBPEftRa14rqp2r4TcluUT1BMAAoQ2dbyjqi1alQn6rZRlbbbB358xNt3pTZaHg28PQhY06v7fi0GYzg9Sw_t-79sORjdKGM_Rq-_9WYXOeDvdlx2rTGdqvhdpzeie-DA59u54tu54o9zZTHY4R-2wYf_SJ5MafYrs78cbWzPvzOiu-WYIBLy6yzl4ac4yL7OLzlCPwHWXNI_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1727688826</pqid></control><display><type>article</type><title>THE POWER OF THE LITTLE BLUE PILL: INNOVATIONS AND IMPLICATIONS OF LIFESTYLE DRUGS IN AN AGING POPULATION</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>LaRiviere, Jacob ; Wolff, Hendrik</creator><creatorcontrib>LaRiviere, Jacob ; Wolff, Hendrik</creatorcontrib><description>The launch of Viagra in April 1998 led to a historically unprecedented high usage of erectile dysfunction (ED) drugs. We test whether Viagra's introduction significantly influenced outcomes for its target population such as sexually transmitted disease (STD) rates of older men, as well as its nontarget populations, such as divorces, natality, the distribution of the age spread within couples, female STDs, and sexual assault rates. We find causal evidence that Viagra's introduction increased gonorrhea rates in older men by 15%–28%. We find no significant evidence of any effects on other variables. We take this as evidence that this lifestyle drug causes significant changes in choices only which affect short‐term outcomes, while long‐term planned decisions are unaffected. Overall, we find that the welfare impacts of Viagra with respect to our outcomes of interest are positive and large. (JEL I1, J1, O33)</description><identifier>ISSN: 0095-2583</identifier><identifier>EISSN: 1465-7295</identifier><identifier>DOI: 10.1111/ecin.12147</identifier><identifier>CODEN: ECIND6</identifier><language>eng</language><publisher>Boston, USA: Wiley Periodicals, Inc</publisher><subject>Anti-impotence agents ; Causality ; Drug use ; Drugs ; Evidence ; Gonorrhea ; Impotence ; Innovation ; Life styles ; Mens health ; Natality ; Product introduction ; Sex crimes ; Sexual abuse ; Sexual disorders ; Sexually transmitted diseases ; STD ; Studies</subject><ispartof>Economic inquiry, 2015-01, Vol.53 (1), p.540-556</ispartof><rights>2014 Western Economic Association International</rights><rights>COPYRIGHT 2015 Blackwell Publishers Ltd.</rights><rights>Copyright Western Economic Association Jan 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6487-f3e9bb69aba8967260e4c224c0c6f3c9bdee1f9a9bc1d7a3bafb53e2eb6f8d133</citedby><cites>FETCH-LOGICAL-c6487-f3e9bb69aba8967260e4c224c0c6f3c9bdee1f9a9bc1d7a3bafb53e2eb6f8d133</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fecin.12147$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fecin.12147$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>LaRiviere, Jacob</creatorcontrib><creatorcontrib>Wolff, Hendrik</creatorcontrib><title>THE POWER OF THE LITTLE BLUE PILL: INNOVATIONS AND IMPLICATIONS OF LIFESTYLE DRUGS IN AN AGING POPULATION</title><title>Economic inquiry</title><addtitle>Econ Inq</addtitle><description>The launch of Viagra in April 1998 led to a historically unprecedented high usage of erectile dysfunction (ED) drugs. We test whether Viagra's introduction significantly influenced outcomes for its target population such as sexually transmitted disease (STD) rates of older men, as well as its nontarget populations, such as divorces, natality, the distribution of the age spread within couples, female STDs, and sexual assault rates. We find causal evidence that Viagra's introduction increased gonorrhea rates in older men by 15%–28%. We find no significant evidence of any effects on other variables. We take this as evidence that this lifestyle drug causes significant changes in choices only which affect short‐term outcomes, while long‐term planned decisions are unaffected. Overall, we find that the welfare impacts of Viagra with respect to our outcomes of interest are positive and large. (JEL I1, J1, O33)</description><subject>Anti-impotence agents</subject><subject>Causality</subject><subject>Drug use</subject><subject>Drugs</subject><subject>Evidence</subject><subject>Gonorrhea</subject><subject>Impotence</subject><subject>Innovation</subject><subject>Life styles</subject><subject>Mens health</subject><subject>Natality</subject><subject>Product introduction</subject><subject>Sex crimes</subject><subject>Sexual abuse</subject><subject>Sexual disorders</subject><subject>Sexually transmitted diseases</subject><subject>STD</subject><subject>Studies</subject><issn>0095-2583</issn><issn>1465-7295</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>N95</sourceid><recordid>eNp90l1vmzAUBmA0bdKydjf7BUi72aaRYRts2F2aEmrJhawhq7Ybyzgmc0ugw6C1_35Ok31kigYSFvbzHh1Zx3FeAX8M7PNBSd2MAQQBeeKMQIBDj8A4fOqMfD8OPRhG6Lnzwpgb3_cRDsORo4uLxJ3n18mVm8_c7Q-jRcES94wt7QFl7KNLsyz_PCloni3cSXbu0ss5o9P9hk0xOksWxRcbOr9apgvrLXMnKc1SW3q-ZI_01HlWidqol_v1xFnOkmJ64bE8tdWYJ3EQEa9CKi5LHItSRDEmEPsqkBAG0pe4QjIuV0qBKhZxKcGKCFSKqgyRgqrEVbQCCJ04b3Z177r2-6BMzzfaSFXXolHtYDjACAfYhwGw9PU_9KYdusZ2xwGBBEdRBPEftRa14rqp2r4TcluUT1BMAAoQ2dbyjqi1alQn6rZRlbbbB358xNt3pTZaHg28PQhY06v7fi0GYzg9Sw_t-79sORjdKGM_Rq-_9WYXOeDvdlx2rTGdqvhdpzeie-DA59u54tu54o9zZTHY4R-2wYf_SJ5MafYrs78cbWzPvzOiu-WYIBLy6yzl4ac4yL7OLzlCPwHWXNI_</recordid><startdate>201501</startdate><enddate>201501</enddate><creator>LaRiviere, Jacob</creator><creator>Wolff, Hendrik</creator><general>Wiley Periodicals, Inc</general><general>Blackwell Publishers Ltd</general><general>Western Economic Association</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>N95</scope><scope>XI7</scope><scope>IBG</scope><scope>8BJ</scope><scope>FQK</scope><scope>JBE</scope><scope>K9.</scope></search><sort><creationdate>201501</creationdate><title>THE POWER OF THE LITTLE BLUE PILL: INNOVATIONS AND IMPLICATIONS OF LIFESTYLE DRUGS IN AN AGING POPULATION</title><author>LaRiviere, Jacob ; Wolff, Hendrik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6487-f3e9bb69aba8967260e4c224c0c6f3c9bdee1f9a9bc1d7a3bafb53e2eb6f8d133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Anti-impotence agents</topic><topic>Causality</topic><topic>Drug use</topic><topic>Drugs</topic><topic>Evidence</topic><topic>Gonorrhea</topic><topic>Impotence</topic><topic>Innovation</topic><topic>Life styles</topic><topic>Mens health</topic><topic>Natality</topic><topic>Product introduction</topic><topic>Sex crimes</topic><topic>Sexual abuse</topic><topic>Sexual disorders</topic><topic>Sexually transmitted diseases</topic><topic>STD</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LaRiviere, Jacob</creatorcontrib><creatorcontrib>Wolff, Hendrik</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>Gale Business: Insights</collection><collection>Business Insights: Essentials</collection><collection>Gale In Context: Biography</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>International Bibliography of the Social Sciences</collection><collection>International Bibliography of the Social Sciences</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>Economic inquiry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LaRiviere, Jacob</au><au>Wolff, Hendrik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>THE POWER OF THE LITTLE BLUE PILL: INNOVATIONS AND IMPLICATIONS OF LIFESTYLE DRUGS IN AN AGING POPULATION</atitle><jtitle>Economic inquiry</jtitle><addtitle>Econ Inq</addtitle><date>2015-01</date><risdate>2015</risdate><volume>53</volume><issue>1</issue><spage>540</spage><epage>556</epage><pages>540-556</pages><issn>0095-2583</issn><eissn>1465-7295</eissn><coden>ECIND6</coden><abstract>The launch of Viagra in April 1998 led to a historically unprecedented high usage of erectile dysfunction (ED) drugs. We test whether Viagra's introduction significantly influenced outcomes for its target population such as sexually transmitted disease (STD) rates of older men, as well as its nontarget populations, such as divorces, natality, the distribution of the age spread within couples, female STDs, and sexual assault rates. We find causal evidence that Viagra's introduction increased gonorrhea rates in older men by 15%–28%. We find no significant evidence of any effects on other variables. We take this as evidence that this lifestyle drug causes significant changes in choices only which affect short‐term outcomes, while long‐term planned decisions are unaffected. Overall, we find that the welfare impacts of Viagra with respect to our outcomes of interest are positive and large. (JEL I1, J1, O33)</abstract><cop>Boston, USA</cop><pub>Wiley Periodicals, Inc</pub><doi>10.1111/ecin.12147</doi><tpages>17</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0095-2583 |
| ispartof | Economic inquiry, 2015-01, Vol.53 (1), p.540-556 |
| issn | 0095-2583 1465-7295 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1636460241 |
| source | Wiley Online Library Journals Frontfile Complete |
| subjects | Anti-impotence agents Causality Drug use Drugs Evidence Gonorrhea Impotence Innovation Life styles Mens health Natality Product introduction Sex crimes Sexual abuse Sexual disorders Sexually transmitted diseases STD Studies |
| title | THE POWER OF THE LITTLE BLUE PILL: INNOVATIONS AND IMPLICATIONS OF LIFESTYLE DRUGS IN AN AGING POPULATION |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T18%3A52%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=THE%20POWER%20OF%20THE%20LITTLE%20BLUE%20PILL:%20INNOVATIONS%20AND%20IMPLICATIONS%20OF%20LIFESTYLE%20DRUGS%20IN%20AN%20AGING%20POPULATION&rft.jtitle=Economic%20inquiry&rft.au=LaRiviere,%20Jacob&rft.date=2015-01&rft.volume=53&rft.issue=1&rft.spage=540&rft.epage=556&rft.pages=540-556&rft.issn=0095-2583&rft.eissn=1465-7295&rft.coden=ECIND6&rft_id=info:doi/10.1111/ecin.12147&rft_dat=%3Cgale_proqu%3EA397134371%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1727688826&rft_id=info:pmid/&rft_galeid=A397134371&rfr_iscdi=true |